Additionally, SPRY1 was reported to play a selective role in a subset of triple-negative breast cancers to promote the malignant phenotype by enhancing the EGF-mediated mesenchymal phenotype [24]. The gene discussed is SPRY1; the disease is triple-negative breast carcinoma.